Andreas Wicki, Director at Pacira Pharmaceuticals, Inc. (PCRX), sold 29,054 shares at $46.18 ($1.4M) on 2018-12-13, disclosed to the SEC on 2018-12-14.
Open-market sale of $1.4M PCRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.84 | 5,807 | $278K | 20.4% |
| 2 | $47.84 | 5,807 | $278K | 20.4% |
| 3 | $46.18 | 8,720 | $403K | 29.6% |
| 4 | $46.18 | 8,720 | $403K | 29.6% |
| Total | $46.84 avg | 29,054 | $1.4M | 100% |
| Filing → |
| HRMY | SELL | 2022-11-16 | $6.1M | — | Filing → |
| HRMY | SELL | 2022-11-10 | $15.2M | — | Filing → |
| HRMY | SELL | 2022-11-04 | $68.2M | — | Filing → |